Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Decreases By 12.6%

Applied DNA Sciences, Inc. (NASDAQ:APDN) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 6,170,000 shares, a decline of 12.6% from the January 15th total of 7,060,000 shares. Based on an average daily volume of 5,290,000 shares, the short-interest ratio is presently 1.2 days.

Applied DNA Sciences Price Performance

NASDAQ APDN opened at $0.17 on Tuesday. The stock has a market capitalization of $9.39 million, a price-to-earnings ratio of -0.02 and a beta of 0.37. Applied DNA Sciences has a one year low of $0.12 and a one year high of $14.40. The business’s fifty day moving average is $0.19 and its 200-day moving average is $0.52.

Applied DNA Sciences (NASDAQ:APDN) last released its earnings results on Thursday, February 13th. The technology company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.24). Applied DNA Sciences had a negative return on equity of 111.18% and a negative net margin of 203.76%. Research analysts expect that Applied DNA Sciences will post -0.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Applied DNA Sciences

Several large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in Applied DNA Sciences during the 3rd quarter valued at about $48,000. Millennium Management LLC purchased a new position in Applied DNA Sciences during the 4th quarter valued at about $28,000. Connective Capital Management LLC purchased a new position in Applied DNA Sciences during the 4th quarter valued at about $36,000. Finally, Geode Capital Management LLC grew its holdings in Applied DNA Sciences by 291.1% during the 4th quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock valued at $85,000 after buying an additional 310,749 shares in the last quarter. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.